<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Clozapine in the Elderly

descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 1994 English Publisher:SAGE PublicationsJournal:Journal of Geriatric Psychiatry and Neurology, volume 7, pages 129-132 (issn: 0891-9887, eissn: 1552-5708,

Authors: Douglas Kalunian; Frances R. Frankenburg;

doi: 10.1177/089198879400700209

pmid: 8204190

Clozapine in the Elderly

- Summary
- Subjects
- Metrics

Abstract

The authors reviewed the use of clozapine in eight patients over age 65 years with treatment-resistant psychoses. Six patients improved. Two patients became more confused. The authors suggest that clozapine be considered in treating elderly psychotic patients, and that its use need not be restricted to schizophrenic patients.

Related Organizations

McLean Hospital
United States

Keywords

Male, Psychiatric Status Rating Scales, Treatment Outcome, Psychotic Disorders, Humans, Female, Clozapine, Aged

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	47
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%